Skip Nav Destination
First Edition
Research Article December 20 2024
Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis
Research Article December 20 2024
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies
Matthew S. Davids,Danielle M Brander,Yesid Alvarado Valero,Catherine Sibyl Diefenbach,Daniel Nathan Egan,Shira Naomi Dinner,Nathalie Javidi-Sharifi,Monzr M. Al Malki,Kebede Begna,Vijaya R. Bhatt,Sameem Abedin,Rachel Cook,Mary C. Collins,Carly Roleder,Edward C Dominguez,Prabhu Rajagopalan,Sandra E Wiley,Richard G Ghalie,Alexey V Danilov
Research Article December 18 2024
Nbeal2 Knockout Mice Are Not Protected Against Hypoxia-Induced Pulmonary Vascular Remodeling and Pulmonary Hypertension
Research Article December 18 2024
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and associated with high response rates.
Ana Rita BM da Fonseca,Caio Cesar Justino,Vinicius Campos de Molla,Patricia Eiko Yamakawa,Iara Baldim Rabelo,Louise M Arnold,Richard J Kelly,Morag Griffin,Talha Munir,Anita Hill,Elvira D R P Velloso,Thales Dalessandro,Antonio Maria Risitano,Phillip Scheinberg,Austin G Kulasekararaj,Celso Arrais-Rodrigues
Research Article December 18 2024
Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma
Research Article December 18 2024
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis
Research Article December 18 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly-diagnosed patients: impact and outcome
Harinder Gill,Radha Raghupathy,Hsin-An Hou,Xavier Cheng-Hong Tsai,Adisak Tantiworawit,Melissa GM Ooi,Gin-Gin Gan,Chieh Lee Wong,Rita Lok Hay Yim,Lynn Chin,Paul Lee,Vivian Wing Kan Li,Lester Au,Qi Zhang,Garret M.K. Leung,Tony K.Y. Wu,Yu Yan Carmen Lee,Wee Joo Chng,Hwei-Fang Tien,Cyrus R. Kumana,Yok-Lam L Kwong
Research Article December 18 2024
Improved Overall Survival with Checkpoint Inhibition and Allogeneic Transplantation in Relapsed Hodgkin Lymphoma
Research Article December 11 2024
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA
Debora Soncini,Pamela Becherini,Francesco Ladisa,Silvia Ravera,Adithya Chedere,Elisa Gelli,Giulia Giorgetti,Claudia Martinuzzi,Francesco Piacente, Dr,Luca Mastracci,Claudia Veneziano, Dr,Gianluca Santamaria, Dr,Fiammetta Monacelli,Moustafa S Ghanem,Antonia Cagnetta,Fabio Guolo, Dr,Matteo Garibotto,Sara Aquino,Mario Passalacqua,Santina Bruzzone,Axel Bellotti,Michel A. Duchosal,Aimable A Nahimana,Emanuele Angelucci,Chandra Nagasuma, Prof,Alessio Nencioni,Roberto Massimo Lemoli,Michele Cea, Prof
Research Article December 11 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Evgenii Shumilov,Rebecca Wurm-Kuczera,Andrea Kerkhoff,Meng Wang,Thomas Melchardt,Udo Holtick,Ulrike Bacher,Philipp B. Staber,Paolo Mazzeo,Corinna Leng,David Böckle,Alexander Sebastian Hölscher,Joseph Kauer,Natalia Rotter,Vladan Vucinic,Jakob D. Rudzki,David Nachbaur,Veit L. Bücklein,Ulf Schnetzke,Isabelle Krämer,Kai Wille,Alexander Hasse,Bastian von Tresckow,Mathias Hänel,Christian Koenecke,Giuliano Filippini Velazquez,Andreas Viardot,Christoph Schmid,Lorenz Thurner,Dominik Wolf,Marion Subklewe,Martin Dreyling,Peter Dreger,Sascha Dietrich,Ulrich Keller,Ulrich Jaeger,Richard Greil,Thomas Pabst,Georg Lenz,Björn Chapuy
Research Article December 10 2024
JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms
Research Article December 10 2024
Health care Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study
Vania Tietsche de Moraes Hungria,Rafael D Gaiolla,Kenny Galvez,Guillermina Remaggi,Natalia Schutz,Rosane Isabel Bittencourt,Angelo Maiolino,Guillermo Enrique Quintero-Vega,Maria Silvana Cugliari,Walter Moises Tobias Braga,Carolina Colaco Villarim,Edvan de Queiroz Crusoé,Alicia Ines Ines Enrico, MD,Gaston Caeiro,Jandey Gloria Bigonha,Fernanda Lemos Moura,Jair Figueroa Emiliani, Dr.,Claudia Sossa-Melo,Milton Lombana,Huiling Pei,Mariana Fernandez,Jaqueline Saes,Damila Cristina Trufelli
Research Article December 10 2024
Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis
Review Article December 9 2024
The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An American Society of Hematology Initiative
Alice Kuaban,Alysha Croker,Jeffrey Keefer,Leonard A. Valentino,Barbara E Bierer,Stephen Boateng,Donna M DiMichele,Patrick Fogarty,Michael C Gibson,Anna M Hood,Lloryn Hubbard,Antonella Isgrò,Karin Knobe,Leslie Lake,Iman Martin,Michel M Reid,Jonathan C Roberts,Wendy Tomlinson,Lanre Tunji-Ajayi, M.S.M,Harriette Van Spall,Caroline Helene Voltz-Girolt,Allison P. Wheeler,Alan E Mast,Stephanie Seremetis
Research Article December 6 2024
Genetic Disruption of Blimp-1 Drastically Augments the Antitumor Efficacy of BCMA-Targeting CAR-T Cells
Research Article December 6 2024
Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management in people with hemophilia A or B
Research Article December 5 2024
Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study
Ofir Wolach,Itai Levi,Boaz Nachmias,Sigal Tavor,irina Amitai,Yishai Ofran,Chezi Ganzel,Tsila Zuckerman,Doaa Okasha,Ilana Hellmann,Tamar Tadmor,Najib Dally,Jonathan Canaani,Galia Stemer,Moshe Grunspan,Adi Jacob Berger,Neta Frankel,Jenia Berelovich,Alexandra Bleterman,Moran Barak,Raanan Cohen,Yakir Moshe
Research Article December 5 2024
Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma
Research Article December 5 2024
Advantages of a genomic DNA-based NGS assay for detection of mutant NPM1 measurable residual disease in AML
Research Article December 4 2024
Impact of Measurable Residual Disease Clearance Kinetics in Patients with AML Undergoing Intensive Chemotherapy
Research Article December 4 2024
Single cell multiomics reveal divergent effects of DNMT3A and TET2 mutant clonal hematopoiesis in inflammatory response
Wazim Mohammed Ismail,Jenna Fernandez,Moritz Binder,Terra L Lasho,Minsuk Kim,Susan Geyer,Amelia Mazzone,Christy M. Finke,Abhishek A Mangaonkar,Jeong-Heon Lee,Liguo Wang,Kwan Hyun Kim,Vernadette A. Simon,Fariborz Rakhshan Rohakthar,Amik Munankarmy,Seul Kee Byeon,Susan M. Schwager,Jonathan J. Harington,Melissa R. Snyder,Keith D. Robertson,Akhilesh Pandey,Eric D. Wieben,Nicholas Chia,Alexandre Gaspar-Maia,Mrinal M. Patnaik
Review Article December 4 2024
New Strategies for Enhancing Enrollment of Underrepresented Minorites in Lymphoma Clinical Trials
Letter December 4 2024
Venetoclax-Proteasome inhibitor-Dexamethasone for unfit patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
Research Article December 3 2024
Peripheral Neuropathy in the Phase 3 ASPEN Study of Bruton Tyrosine Kinase Inhibitors for Waldenström Macroglobulinemia
Benjamin M. Heyman,Stephen S. Opat,Björn E. Wahlin,Meletios Athanasios A. Dimopoulos,Jorge J. Castillo,Alessandra Tedeschi,Constantine S. Tam,Christian Buske,Roger G. Owen,Véronique Leblond,Judith Trotman,Gisoo Barnes,Wai Y. Chan,Jingjing Schneider,Heather Allewelt,Aileen Cleary Cohen,Jeffrey V. Matous
Research Article December 3 2024
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
Andrew J. Yee,Jacob P Laubach,Erica L. Campagnaro,Brea C. Lipe,Omar Nadeem,Robb S Friedman,Craig E. Cole,Elizabeth O'Donnell,Giada Bianchi,Andrew R Branagan,Robert L. Schlossman,Samantha J. Shaprio,Cynthia C. Harrington,Jill N. Burke,Marilyn T. Gammon,Kathleen J. Lively,Cassandra A. Reimonn,Danielle X. Andrade,Robert A Redd,Jens G. Lohr,Kenneth C. Anderson,Paul G. Richardson,Noopur Raje
Research Article December 3 2024
Congenital T cell activation impairs transitional to follicular B cell maturation in humans
Hugues Allard-Chamard,Kirsty Hillier,Michelle L. Ramseier,Alice Bertocchi,Naoki Kaneko,Katherine Premo,Grace Yuen,Marshall Karpel,Vinay S. Mahajan,Christina Tsekeri,Joseph S. Hong,Jean Vencic,Anish V. Sharda,Sara Barmettler,Emma Westermann-Clark,Jolan E. Walter,Musie Ghebremichael,Alex K. Shalek,Jocelyn R. Farmer,Shiv Pillai
Research Article December 3 2024
Relapse Free Survival Progressive Shortens in a Subset of Black patients with Immune TTP Treated in the Rituximab Era
Ayotola A Fatola,Michael D Evans,Jenna Brown,Elizabeth Davis,Andrew David Johnson,Ana G. Antun,Andrew Farland,Ryan Woods,Ara Metjian,Yara Park,Gustaaf de Ridder,Briana Gibson,Raj S Kasthuri,Darla K Liles,Susan Eubanks,Frank Akwaa,Todd Clover,Lisa Baumann Kreuziger,J. Evan Evan Sadler,Meera Sridharan,Ronald S Go,Keith R McCrae,Harsh Vardhan Upreti,Ming Y Lim,Nicole Katlyn Kocher,Radhika Gangaraju,X. Long Zheng,Jay S Raval,Camila Masias,Spero R. Cataland,Marshall Mazepa,Shruti Chaturvedi
Research Article December 3 2024
Antiviral potential of Vδ2 T-cells in children given TCR αβ/CD19 cell depleted HLA-haploidentical HSCT
Research Article December 3 2024
Inaticabtagene Autoleucel (CNCT19) in adult relapsed or refractory B-cell acute lymphoblastic leukemia
Research Article December 3 2024
Anxiety and Depression in Patients with Histiocytic Neoplasms and their Associated Clinical Features
Research Article December 3 2024
Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs)
Emily C. Liang,Jennifer J. Huang,Andrew J. Portuguese,Valentín Ortiz-Maldonado,Aya Albittar,Natalie Wuliji,Ryan Basom,Yein Jeon,Qian (Vicky) Wu,Aiko Torkelson,Delaney R. Kirchmeier,Abigail Chutnik,Barbara S. Pender,Mohamed L Sorror,Joshua A Hill,Noam E. Kopmar,Rahul Banerjee,Andrew J Cowan,Damian J Green,Ajay K. Gopal,Christina Poh,Mazyar Shadman,Alexandre V. Hirayama,Brian G. Till,Erik L. Kimble,Lorenzo Iovino,Aude G Chapuis,Folashade Otegbeye,Ryan D. Cassaday,Filippo Milano,Cameron J. Turtle,David G Maloney,Jordan Gauthier
Research Article December 2 2024
RAPID-CRISPR: Highly Sensitive Diagnostic Assay for Detection of PML-RARA Isoforms in Acute Promyelocytic Leukemia
Research Article November 27 2024
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium
Jonathan R Day,Melissa C. Larson,Urshila Durani,Jean L Koff,Yucai Wang,Thomas M. Habermann,Izidore S Lossos,Loretta J. Nastoupil,Christopher S Strouse,Dai Chihara,Peter Martin,John P. Leonard,Jonathon B Cohen,Brad S. Kahl,Jia Ruan,Richard Burack,Jonathan W. Friedberg,James R Cerhan,Christopher R. Flowers,Brian L Link,Matthew J. Maurer,Carla Casulo
Letter November 27 2024
Generalized Additive Logit Models for Clinical Prediction
Research Article November 27 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma
Inés Zugasti,Marta Tormo-Ratera,Aina Oliver-Caldes,Juan Carlos Soler-Perromat,Veronica Gonzalez-Calle,David F Moreno,Valentín Cabañas,Nieves Lopez-Muñoz,Alvaro Bartolome-Solanas,Marta Español-Rego,Juan Luis Reguera-Ortega,Laura Rosiñol,Lucia Lopez-Corral,Natalia Tovar,Luis Gerardo Rodríguez-Lobato,Rosa Maria Alvarez Perez,Sara Varea,Eulàlia Olesti,Adolfo Gomez Grande,Laura Frutos,Pilar Tamayo,Manel Juan,José M Moraleda,Álvaro Urbano-Ispizua,Europa Azucena Azucena González-Navarro,Joaquín Martínez-López,Maria-Victoria Mateos,Xavier Tomas,Xavier Setoain,Carlos Fernández de Larrea
Research Article November 27 2024
COMPARABLE OUTCOMES AFTER BUSULFAN- OR TREOSULFAN-BASED CONDITIONING FOR ALLO-HSCT IN CHILDREN WITH ALL-RESULTS OF FORUM
Krzysztof Kałwak,Laura M. Moser,Ulrike Pötschger,Peter Bader,Katharina Kleinschmidt,Roland Meisel,Jean-Hugues Dalle,M. Akif Yeşilipek,Adriana Cristina Balduzzi,Gergely Kriván,Evgenios Goussetis,Raquel Staciuk,Petr Sedlacek,Herbert Pichler,Peter Svec,Melissa Gabriel,Tayfun Güngör,Ernest Bilic,Jochen Buechner,Marleen Renard,Kim Vettenranta,Marianne Ifversen,Cristina Diaz-de-Heredia,Jerry Stein,Jacek Toporski,Marc B Bierings,Christina Peters,Marc Ansari,Franco Locatelli
